Inhibiting MCF-7 Cell Epithelial-mesenchymal Transition Induced by TGF-βwith Rho Signaling Pathway Inhibitor Y27632

WANG Nan,ZHUANG Chunyu,SONG Tiefeng,YUAN Ying,ZHANG Rui,ZHANG Tongcun
DOI: https://doi.org/10.13364/j.issn.1672-6510.20150005
2015-01-01
Abstract:It is reported that epithelial-mesenchymal transition(EMT)plays an important role in the process of breast cancer development. TGF-βis reported to be the key factor during the EMT progress. Multiple signaling pathways are involved in EMT. Whether Rho/ROCK pathway is involved in EMT is unclear. First,TGF-β-induced EMT model was established. The migration abilities of MCF-7 were evaluated by wound-healing assay and the expression of mesenchymal markers were de-tected by real-time PCR and western blotting. To investigate the role of Rho pathway in TGF-β-induced MCF-7 cell EMT, specific inhibitor Y27632 was added in MCF-7 cells with/without TGF-β. The results showed that TGF-βdid induce EMT and migration,and Y27632 really inhibited TGF-β-induced EMT and migration in MCF-7.
What problem does this paper attempt to address?